Brief: Lumiradx Receives UK MHRA Approval For Sars-Cov-2 RNA STAR Complete

LumiraDx

21/02/2022 09:21

Feb 21 (Reuters) - LumiraDx Ltd  LMDX.O :
    * LUMIRADX RECEIVES UK MHRA APPROVAL FOR SARS-COV-2 RNA STAR
COMPLETE
    * LUMIRADX LTD- HAS BEEN SUCCESSFULLY VALIDATED CTDA AND
RECEIVED
UK MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA)
APPROVAL
    * LUMIRADX LTD - IN CLINICAL STUDIES, ASSAY DEMONSTRATED
95.4%
POSITIVE AGREEMENT WHEN COMPARED TO ANOTHER HIGH SENSITIVITY
RT-PCR ASSAY.

Source text for Eikon:  ID:nPrec1M3Ra 
Further company coverage:  LMDX.O 

 ((reuters.briefs@thomsonreuters.com;))